Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Tsumura & Co ( (JP:4540) ).
Tsumura & Co. has announced an additional monetary contribution to its trust-type stock delivery system for employees, known as the Stock Grant ESOP Trust. This decision aims to secure funds for acquiring shares to be delivered to eligible employees, enhancing employee engagement and aligning their interests with the company’s performance.
The most recent analyst rating on (JP:4540) stock is a Buy with a Yen4044.00 price target. To see the full list of analyst forecasts on Tsumura & Co stock, see the JP:4540 Stock Forecast page.
More about Tsumura & Co
Tsumura & Co. operates in the pharmaceutical industry, focusing on the production and distribution of traditional Japanese Kampo medicines. The company is listed on the Tokyo Stock Exchange Prime Market and is known for its commitment to integrating traditional medicine with modern healthcare practices.
Average Trading Volume: 545,371
Technical Sentiment Signal: Hold
Current Market Cap: Yen279.5B
For detailed information about 4540 stock, go to TipRanks’ Stock Analysis page.